Entries of Lordick, F on the publication server
 | Up a level |
Number of items: 2.
2010
Lordick, F, Luber, B, Lorenzen, S, Hegewisch-Becker, S, Folprecht, G 
, Wöll, E, Decker, T, Endlicher, E, Röthling, N, Schuster, T, Keller, G, Fend, F and Peschel, C
(2010)
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
British Journal of Cancer 102 (3), pp. 500-505.
Fulltext not available.
, Wöll, E, Decker, T, Endlicher, E, Röthling, N, Schuster, T, Keller, G, Fend, F and Peschel, C
(2010)
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
British Journal of Cancer 102 (3), pp. 500-505.
Fulltext not available.
2005
Lordick, F, Lorenzen, S, Stollfuss, J, Vehling-Kaiser, U, Kullmann, F, Hentrich, M, Zumschlinge, R, Dietzfelbinger, H, Thoedtmann, J, Hennig, M, Seroneit, T, Bredenkamp, R, Duyster, J and Peschel, C
(2005)
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.
British Journal of Cancer 93 (2), pp. 190-194.
Fulltext not available.